Last reviewed · How we verify

NCT06268431: ORCA

Oxytocin Rest to Reduce Cesarean Delivery

Recruiting now NA Last updated 17 October 2024
What this trial tests

NA trial testing Oxytocin rest in Prolonged Labor in 350 participants. Currently enrolling.

Timeline
19 March 2024
Primary endpoint
15 February 2026
15 March 2026

Quick facts

Lead sponsorChristiana Care Health Services
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment350
Start date19 March 2024
Primary completion15 February 2026
Estimated completion15 March 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Christiana Care Health Services — full company profile →

Who can join

Adults 18 to 55, female only, with Prolonged Labor or Failed Induction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prolonged labor is usually managed with continuous oxytocin infusion. "Oxytocin rest" has been proposed as a strategy to resolve protracted labor in patients who have received continuous oxytocin without progress. This strategy involves discontinuing oxytocin then restarting infusion after a period of time, under the theory that washout of the oxytocin receptor will strengthen uterine contractions to improve labor progress. "Oxytocin rest" is performed on labor and delivery units across the United States. Yet, there is no randomized or prospective data to support the practice. The purpose of this study is to assess whether oxytocin rest of 60 minutes in patients with prolonged labor reduces risk for cesarean delivery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Prolonged Labor

Currently open trials in the same condition.

Other Christiana Care Health Services trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06268431.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing